[ad_1]
Malvern, Pa., Feb. 21, 2024 (GLOBE NEWSWIRE) — Ocugen, Inc. (“Ocugen” or the “Company”) (NASDAQ: OCGN) is a biotechnology company focused on discovering, developing and commercializing novel genes and technologies. technology company. Cell Therapy and Vaccines, today announced that Ocugen Chairman, CEO and Co-Founder Dr. Shankar Musunuri will attend the BIO CEO and Investor Conference on February 26-27, 2024 at the Marriott Marquis Hotel in New York City.
Members of the Ocugen leadership team will conduct one-on-one meetings with registered investors and pharmaceutical companies to present the company’s business and clinical development strategies, recent corporate achievements and anticipated milestones.
Details of the speech are as follows:
Event: BIO CEO and Investor Conference
Date: Monday, February 26, 2024
Demo time: 1:45 p.m. ET
Location: Plymouth Room, Marriott Marquis, New York City
Registration: https://bcic.bio.org/registration
Attendees who would like to schedule a meeting with Ocugen’s leadership team are encouraged to register through the BIO CEO attendee portal.
About Ocugen, Inc.
Ocugen, Inc. is a biotechnology company focused on discovering, developing and commercializing novel gene and cell therapies, biologics and vaccines to improve health and bring hope to patients around the world. Through bold innovation, we leverage our unique intellectual and human capital to pioneer new scientific pathways that impact patient lives. Our breakthrough modified gene therapy platform has the potential to treat multiple retinal diseases with a single product, and we are advancing infectious disease research to support public health and orthopedic diseases to address unmet medical needs.Discover more at www.ocugen.com and follow us Twitter and LinkedIn.
forward-looking statements
This press release contains forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995 that involve risks and uncertainties. In some cases, we may use the words “forecast”, “believe”, “potential”, “proposal”, “continue”, “estimate”, “anticipate”, “expect”, “plan”, “intend”, etc. the term. These forward-looking statements are identified by words such as “may,” “could,” “could,” “will,” “should” or other words that convey uncertainty about future events or results. Such statements are subject to a number of important factors, risks and uncertainties that could cause actual events or results to differ materially from our current expectations. These and other risks and uncertainties are more fully described in our periodic filings with the Securities and Exchange Commission (SEC), including in the section titled “Risk Factors” in our quarterly and annual reports filed with the SEC Describe the risk factors. Any forward-looking statements we make in this press release speak only as of the date of this press release. Except as required by law, we undertake no obligation to update the forward-looking statements contained in this press release, whether as a result of new information, future events or otherwise, after the date of this press release.
touch:
Tiffany Hamilton
communications director
Tiffany.Hamilton@ocugen.com
[ad_2]
Source link